Absent T Lymphocytes

Search Trials
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Status:
Recruiting
Last Changed:
Sep 16, 2021
First Changed:
May 31, 2019
Disease(s):
Solid Tumor
Intervention(s):
NeoTCR-P1 adoptive cell therapynivolumabIL-2
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
Status:
Completed
Last Changed:
May 9, 2017
First Changed:
Jul 31, 2007
Disease(s):
Cancer
Intervention(s):
cytomegalovirus pp65-specific cytotoxic T lymphocytespolymerase chain reactiondiagnostic laboratory biomarker analysisflow cytometryimmunologic technique
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Status:
Unknown status
Last Changed:
Dec 18, 2013
First Changed:
Oct 9, 2008
Disease(s):
Cancer
Intervention(s):
cytomegalovirus IE-1-specific cytotoxic T lymphocytescytomegalovirus pp65-specific cytotoxic T lymphocytestherapeutic allogeneic lymphocytespolymerase chain reactionflow cytometryimmunological diagnostic methodlaboratory biomarker analysis
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
Status:
Recruiting
Last Changed:
Nov 3, 2021
First Changed:
Jul 18, 2019
Disease(s):
Non-Small Cell Lung Cancer
Intervention(s):
CART-TnMUC1CyclophosphamideFludarabine
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Status:
Recruiting
Last Changed:
Dec 22, 2021
First Changed:
Feb 21, 2019
Disease(s):
Melanoma
Intervention(s):
XmAb®22841Pembrolizumab (Keytruda®)

Connect. Empower. Inspire.